Literature DB >> 15339767

Inverse correlation between maternal weight and second trimester circulating cell-free fetal DNA levels.

Tuangsit Wataganara1, Inga Peter, Geralyn M Messerlian, Lynn Borgatta, Diana W Bianchi.   

Abstract

OBJECTIVE: Clinical applications of the analysis of cell-free fetal DNA in maternal plasma and serum are expanding. However, use of fetal DNA during prenatal screening requires knowledge of variables that might affect its levels in the maternal circulation. We conducted this study to estimate the effect of selected demographic factors on fetal DNA levels in the first and second trimesters of pregnancy.
METHODS: We developed a database that included fetal DNA levels and clinical information, such as maternal age, ethnicity, weight, and smoking history. We measured fetal DNA levels in maternal plasma and serum using real-time quantitative polymerase chain reaction amplification of a Y chromosome specific sequence. The fetal DNA data from fresh first trimester plasma and previously frozen second trimester serum samples were analyzed separately. Fetal DNA levels were adjusted according to gestational age and storage time and then analyzed in association with the demographic factors.
RESULTS: In the first trimester group, no significant association between maternal age, weight, ethnic background, or smoking and plasma fetal DNA levels was observed. In the second trimester group, a significant inverse correlation between maternal weight and serum fetal DNA level was demonstrated (r = -0.26, P =.007). This was especially prominent when the mothers weighed more than 170 lb (P =.001). Maternal age, ethnicity, and smoking were not significantly associated with the second trimester serum fetal DNA levels.
CONCLUSION: Fetal DNA levels are affected by maternal weight in the second trimester. A correction for this effect may be needed in larger-scale studies or for future clinical applications that measure cell-free fetal nucleic acids in maternal circulation.

Mesh:

Substances:

Year:  2004        PMID: 15339767     DOI: 10.1097/01.AOG.0000137352.93110.15

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  13 in total

1.  Cell-Free Total and Fetal DNA in First Trimester Maternal Serum and Subsequent Development of Preeclampsia.

Authors:  Robert M Silver; Leslie Myatt; John C Hauth; Kenneth J Leveno; Alan M Peaceman; Susan M Ramin; Philip Samuels; George Saade; Yoram Sorokin; Rebecca G Clifton; Uma M Reddy
Journal:  Am J Perinatol       Date:  2016-07-11       Impact factor: 1.862

2.  Trophoblastic oxidative stress and the release of cell-free feto-placental DNA.

Authors:  May Lee Tjoa; Tereza Cindrova-Davies; Olivera Spasic-Boskovic; Diana W Bianchi; Graham J Burton
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

3.  A multifactorial relationship exists between total circulating cell-free DNA levels and maternal BMI.

Authors:  Neeta L Vora; Kirby L Johnson; Subhabrata Basu; Patrick M Catalano; Sylvie Hauguel-De Mouzon; Diana W Bianchi
Journal:  Prenat Diagn       Date:  2012-06-21       Impact factor: 3.050

4.  Circulating cell-free DNA levels increase variably following chorionic villus sampling.

Authors:  Neeta L Vora; Kirby L Johnson; Inga Peter; Hocine Tighiouart; Steven J Ralston; Sabrina D Craigo; Diana W Bianchi
Journal:  Prenat Diagn       Date:  2010-04       Impact factor: 3.050

5.  The Effect of Maternal Obesity on Placental Cell-Free DNA Release in a Mouse Model.

Authors:  Mohak Mhatre; Sharareh Adeli; Errol Norwitz; Sabrina Craigo; Mark Phillippe; Andrea Edlow
Journal:  Reprod Sci       Date:  2018-11-19       Impact factor: 3.060

6.  Cell-free DNA fragmentation patterns in amniotic fluid identify genetic abnormalities and changes due to storage.

Authors:  Inga Peter; Hocine Tighiouart; Olav Lapaire; Kirby L Johnson; Diana W Bianchi; Norma Terrin
Journal:  Diagn Mol Pathol       Date:  2008-09

7.  Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics.

Authors:  Anthony R Gregg; Brian G Skotko; Judith L Benkendorf; Kristin G Monaghan; Komal Bajaj; Robert G Best; Susan Klugman; Michael S Watson
Journal:  Genet Med       Date:  2016-07-28       Impact factor: 8.822

8.  Non-invasive prenatal diagnosis using cell-free fetal nucleic acids in maternal plasma: Progress overview beyond predictive and personalized diagnosis.

Authors:  Georgia Tounta; Aggeliki Kolialexi; Nikolas Papantoniou; George Th Tsangaris; Emmanuel Kanavakis; Ariadni Mavrou
Journal:  EPMA J       Date:  2011-05-17       Impact factor: 6.543

9.  Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women.

Authors:  Maricela Haghiac; Neeta L Vora; Subhabrata Basu; Kirby L Johnson; Larraine Presley; Diana W Bianchi; Sylvie Hauguel-de Mouzon
Journal:  Obesity (Silver Spring)       Date:  2012-06-07       Impact factor: 5.002

10.  Low fetal fraction in obese women at first trimester cell-free DNA based prenatal screening is not accompanied by differences in total cell-free DNA.

Authors:  Raj Shree; Teodora R Kolarova; Hayley J MacKinnon; Jaclynne M Hedge; Elena Vinopal; Kimberly K Ma; Christina M Lockwood; Suchitra Chandrasekaran
Journal:  Prenat Diagn       Date:  2021-08-14       Impact factor: 3.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.